Johnson & Johnson's HIV vaccine candidate has failed its first major efficacy test, as it was unable to protect women against infection with the virus in a phase 2b trial carried out in sub ...

The first human clinical trials testing a new strategy to protect against HIV infections have yielded promising early results ...

South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7,000 babies ...

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group on the African continent. In 2023, more ...

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group are on the African continent. In 2023, more ...

32, No. 2, Jun., 2006 Protecting Young Women from HIV/AIDS: Th... Protecting Young Women from HIV/AIDS: The Case against Child and Adolescent Marriage This is the metadata section. Skip to content ...

Anti-HIV mRNA vaccines are already in development, some in early-stage human trials. There is no evidence that mRNA vaccines can alter human DNA. Yes, an mRNA vaccine might well work against HIV, and ...